Researchers in the lab of James Poulet have uncovered how the nervous system senses cool and warm temperatures. The findings, published in “Neuron” challenge a long-standing view of temperature sensing and could guide future research into pain and…
Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 study.
With the vast majority of PMD patients having no FDA-approved therapeutic option, OMT-28 addresses…
Application deadline: August 3, 2026
Researchers in the Mina Gouti lab show in “Advanced Science” that electrical pulse stimulation helps human neuromuscular organoids mature. This non-invasive approach may make it possible to use organoid models to study adult-onset diseases and to…
Reporting in “Nature,” a team led by Gary Lewin at the Max Delbrück Center has found that naked mole-rat queens produce an odorous chemical that ensures that only they can reproduce. The queen odor also prevents rivalry within colonies — even when…
x-cardiac GmbH, a company in the field of AI-powered medical devices, has broadened its business focus to AI solutions for everyday clinical use while simultaneously rebranding as Ascléa GmbH. At the same time, a Series A funding round has been…
Leibniz Association recommends continued funding of the DRFZ
Deadline: September 22, 2026
March 17 - 21 2027 | Aplication deadline: November 15, 2026
Closing: 08 September 2026: AI-BOOST and EUCAIM have launched the joint challenge 'Generative AI for Enhancement of Clinical Datasets'.
